366 related articles for article (PubMed ID: 35785029)
1. Mast Cell Activation Syndrome in COVID-19 and Female Reproductive Function: Theoretical Background vs. Accumulating Clinical Evidence.
Szukiewicz D; Wojdasiewicz P; Watroba M; Szewczyk G
J Immunol Res; 2022; 2022():9534163. PubMed ID: 35785029
[TBL] [Abstract][Full Text] [Related]
2. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome.
Afrin LB; Weinstock LB; Molderings GJ
Int J Infect Dis; 2020 Nov; 100():327-332. PubMed ID: 32920235
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of Post-COVID syndromes: a new perspective.
Batiha GE; Al-Kuraishy HM; Al-Gareeb AI; Welson NN
Virol J; 2022 Oct; 19(1):158. PubMed ID: 36210445
[TBL] [Abstract][Full Text] [Related]
4. Mast cell activation symptoms are prevalent in Long-COVID.
Weinstock LB; Brook JB; Walters AS; Goris A; Afrin LB; Molderings GJ
Int J Infect Dis; 2021 Nov; 112():217-226. PubMed ID: 34563706
[TBL] [Abstract][Full Text] [Related]
5. Effects of Infection with SARS-CoV-2 on the Male and Female Reproductive Systems: A Review.
Liu C; Mu C; Zhang Q; Yang X; Yan H; Jiao H
Med Sci Monit; 2021 Jul; 27():e930168. PubMed ID: 34193809
[TBL] [Abstract][Full Text] [Related]
6. Some cases of hypermobile Ehlers-Danlos syndrome may be rooted in mast cell activation syndrome.
Afrin LB
Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):466-472. PubMed ID: 34719842
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome?
Theoharides TC; Conti P
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1633-1636. PubMed ID: 33023287
[TBL] [Abstract][Full Text] [Related]
8. Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding.
Afrin LB; Dempsey TT; Rosenthal LS; Dorff SR
J Obstet Gynaecol; 2019 Jul; 39(5):664-669. PubMed ID: 30964355
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome.
Schmidt TJ; Sellin J; Molderings GJ; Conrad R; Mücke M
Orphanet J Rare Dis; 2022 Jul; 17(1):295. PubMed ID: 35906626
[TBL] [Abstract][Full Text] [Related]
10. Mast cell activation syndrome: Myths and realities.
Zhang S; Bernstein JA
Allergy Asthma Proc; 2021 May; 42(3):198-204. PubMed ID: 33980332
[No Abstract] [Full Text] [Related]
11. Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders.
Muñoz-González JI; García-Montero AC; Orfao A; Álvarez-Twose I
Ann Allergy Asthma Immunol; 2021 Oct; 127(4):427-434. PubMed ID: 34298172
[TBL] [Abstract][Full Text] [Related]
12. Mast cell activation syndrome in pregnancy, delivery, postpartum and lactation: a narrative review.
Dorff SR; Afrin LB
J Obstet Gynaecol; 2020 Oct; 40(7):889-901. PubMed ID: 32148151
[TBL] [Abstract][Full Text] [Related]
13. Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders.
Rossignol J; Ouedrani A; Livideanu CB; Barete S; Terriou L; Launay D; Lemal R; Greco C; Frenzel L; Meni C; Bodemere-Skandalis C; Polivka L; Collange AF; Hachichi H; Bouzourine S; Messaoud DN; Negretto M; Vendrame L; Jambou M; Gousseff M; Durupt S; Lega JC; Durand JM; Gaudy C; Damaj G; Gourin MP; Hamidou M; Bouillet L; Le Mouel E; Maria A; Zunic P; Cabrera Q; Vincent D; Lavigne C; Riviere E; Gourguechon C; Courbebaisse M; Lebeaux D; Parfait B; Friedlander G; Brignier A; Lhermitte L; Molina TJ; Bruneau J; Agopian J; Dubreuil P; Ranta D; Mania A; Arock M; Staropoli I; Tournilhac O; Lortholary O; Schwartz O; Chatenoud L; Hermine O
J Allergy Clin Immunol Pract; 2022 May; 10(5):1356-1364.e2. PubMed ID: 35074600
[TBL] [Abstract][Full Text] [Related]
14. Mast cell activation syndrome and the link with long COVID.
Arun S; Storan A; Myers B
Br J Hosp Med (Lond); 2022 Jul; 83(7):1-10. PubMed ID: 35938771
[TBL] [Abstract][Full Text] [Related]
15. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis.
Di Mascio D; Khalil A; Saccone G; Rizzo G; Buca D; Liberati M; Vecchiet J; Nappi L; Scambia G; Berghella V; D'Antonio F
Am J Obstet Gynecol MFM; 2020 May; 2(2):100107. PubMed ID: 32292902
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine.
Valent P; Akin C; Nedoszytko B; Bonadonna P; Hartmann K; Niedoszytko M; Brockow K; Siebenhaar F; Triggiani M; Arock M; Romantowski J; Górska A; Schwartz LB; Metcalfe DD
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261124
[TBL] [Abstract][Full Text] [Related]
17. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
18. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls.
DeBolt CA; Bianco A; Limaye MA; Silverstein J; Penfield CA; Roman AS; Rosenberg HM; Ferrara L; Lambert C; Khoury R; Bernstein PS; Burd J; Berghella V; Kaplowitz E; Overbey JR; Stone J
Am J Obstet Gynecol; 2021 May; 224(5):510.e1-510.e12. PubMed ID: 33221292
[TBL] [Abstract][Full Text] [Related]
19. Learned cautions regarding antibody testing in mast cell activation syndrome.
Afrin LB; Dempsey TT; Molderings GJ
Diagnosis (Berl); 2023 Nov; 10(4):424-431. PubMed ID: 37566881
[TBL] [Abstract][Full Text] [Related]
20. Restless legs syndrome is associated with mast cell activation syndrome.
Weinstock LB; Walters AS; Brook JB; Kaleem Z; Afrin LB; Molderings GJ
J Clin Sleep Med; 2020 Mar; 16(3):401-408. PubMed ID: 31994488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
